{"schema_version":"secwatch.filing_event.v1","accession":"0000012208-24-000015","form_type":"8-K","ticker":"BIO","cik":"0000012208","company_name":"BIO-RAD LABORATORIES, INC.","filed_at":"2024-02-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.602845+00:00","generated_at":"2026-06-05T21:44:20.153107+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Bio-Rad discloses Sartorius AG FY 2023 results: revenue €3.4B, net profit €290M","bullets":["Sartorius AG FY 2023 sales revenue €3,395.7M, gross profit €1,567.1M.","EBIT €503.9M, net profit €290.0M for the year ended Dec 31, 2023.","Operating cash flow €853.6M; investing cash flow -€2,823.3M; financing cash flow €2,165.7M.","Total assets €9,755.4M, equity €2,757.4M as of Dec 31, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000012208-24-000015","json":"https://secwatch.observer/filing/0000012208-24-000015.json","markdown":"https://secwatch.observer/filing/0000012208-24-000015.md","text":"https://secwatch.observer/filing/0000012208-24-000015.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/12208/000001220824000015/0000012208-24-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/12208/000001220824000015/bio-20240221.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T21:44:20.153107+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}